Robert F. Williamson III, Director at Perspective Therapeutics, Inc. (CATX), bought 120,674 shares at $2.14 ($264K) on 2025-03-31, disclosed to the SEC on 2025-04-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.27 | 22,192 | $50K | 19.1% |
| 2 | $2.27 | 22,192 | $50K | 19.1% |
| 3 | $2.14 | 38,145 | $82K | 30.9% |
| 4 | $2.14 | 38,145 | $82K | 30.9% |
| Total | $2.19 avg | 120,674 | $264K | 100% |
| Filing → |
| CATX | BUY | 2024-06-03 | $76K | — | Filing → |
| CATX | BUY | 2024-05-30 | $40K | — | Filing → |
| CATX | BUY | 2024-02-01 | $91K | — | Filing → |